Siemens is showcasing the capabilities of its Mammomat NovationDR FFDM platform for screening, diagnostics and biopsy applications. It is designed to handle the mammography workup from patient registration and image acquisition to post-processing and reading.
Also on display is the Mammomat Inspiration, which is not yet available in the United States. It is exclusively designed for digital mammography applications, supports the needs of a screening environment, and is prepared for future 3D tomosynthesis.
The company is featuring its MammoTest, a biopsy system which visualizes micro-calcifications and diagnosing masses. It offers a large variety of needles and wire localization devices and offers easy patient access. The syngo Opdima is designed to perform digital stereotactic biopsy, as well as spot imaging. It is compatible with Mammomat NovationDR and Mammomat 3000 Nova systems.
The syngo MammoReport is a dedicated high-speed breast-care workspace for reading and reporting mammograms in screening and diagnostics. Features include true multi-modality viewing, including ultrasound and MRI; high-speed access to all image data, RIS integration; and advanced data handling and display.
Siemens also is presenting a new ultrasound portfolio featuring workflow-enhancing applications across the Acuson P, X, and S Class products. The Acuson S2000 ABVS Automated Breast Volume Scanner (ABVS) streamlines workflow and reduces operator dependence and variability by surveying and acquiring full-field sonographic volumes for comprehensive review and diagnosis of the breast. The system features an integrated room suite design combining the Acuson S2000 ultrasound system and a column stand with an arm assembly holding a transducer pod specially designed for automated ultrasound breast imaging. Approximately 250 to 400 single images are acquired in one scan to calculate the volumes, which are sent to a dedicated ABVS Workplace for analysis and manipulation.
The Acuson S2000 ABVS system features the anatomical coronal plane, which is not available using conventional ultrasound. Semi-automated reporting features and comprehensive BI-RADS report capabilities further enhance the clinical workflow. The Acuson S2000 ABVS is pending FDA 510(k) approval, and is not yet commercially available in the United States, Siemens says.
The company is showcasing its tissue strain analytics, a new ultrasound application that enables visual or numerical measurements of the mechanical stiffness of tissue. This new dimension of information, which is not available using conventional sonographic imaging, represents the most significant advancement in ultrasound technology since the advent of Doppler imaging, according to the company.
Tissue strain analytics features three applications: Virtual Touch tissue imaging, exclusively on the Acuson S2000 ultrasound system, allows clinicians to create a relative stiffness map for any region of interest. Virtual Touch tissue quantification provides a numerical value of shear wave speed related to tissue stiffness at a precise anatomical location; and eSie Touch elasticity imaging, available on both the Acuson Antares and Acuson S2000 systems, enables high-resolution elastography using both superficial and endocavity transducers.
The new, high-density 18L6 HD transducer coupled with the Acuson S2000 ultrasound system provides detail of complex pathological masses and subtle lesions in breast imaging. The S2000 system features extended diagnostic capabilities offering innovative clinical applications in breast elasticity and Virtual Touch technology, which is the first implementation of Acoustic Radiation Force Imaging in a commercially available ultrasound system, according to Siemens. The system also is ready to integrate silicon transducers, a next-generation transducer technology.